Top 23 Spero Therapeutics investors
The most complete profiles first. Showing 23 of 23.
Jernej GodecVerified
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Verified email available
Kevin BittermanVerified
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 70 more
Verified email available
Louis BernemanVerified
Venture Capital, University Program, Entrepreneurship Program · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Verified email available
Manny StockmanVerified
Venture Capital, University Program, Entrepreneurship Program · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Verified email available
Meredith FisherVerified
Venture Capital, Investor · United States
SeedHealth CareWellnessWomen FoundedLife SciencePortfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more
Verified email available
Robert AdelsonVerified
Venture Capital, University Program, Investor · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 65 more
Verified email available
Roger KittermanVerified
Venture Capital, Investor · United States
SeedHealth CareWellnessWomen FoundedLife SciencePortfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more
Verified email available
Alex HardingVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Verified email available
Anurag AgarwalVerified
Venture Capital, University Program, Entrepreneurship Program · United States
Health CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Verified email available
Jason RhodesVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Verified email available
Matt CohenVerified
Venture Capital, University Program · United States
Health CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Verified email available
Matthew FoyVerified
Corporate Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Semprus BioSciences, Pulmocide, Syntaxin, CRISPR Therapeutics and 50 more
Verified email available
Carl Berke
Venture Capital, Investor · United States
SeedHealth CareWellnessWomen FoundedLife SciencePortfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more
Contact details available
Marc Singer
Venture Capital, University Program, Entrepreneurship Program · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 69 more
Contact details available
William Harrington
Venture Capital, University Program, Investor · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 71 more
Contact details available
Jean
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Contact details available
Jean
Venture Capital · United States
BiotechnologyPortfolio: Ataxion, Intellia Therapeutics, Spero Therapeutics, IFM Therapeutics and 6 more
Contact details available
Julius Knowles
Venture Capital, Design Operator, Strategy Operator · United States
Health CareHospitalsWellnessWomen FoundedPortfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more
Contact details available
Kirsten Leute
Venture Capital, University Program · United States
Health CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Contact details available
Ruoxi Hu
Venture Capital · United States
Health CareWellnessWomen FoundedLife SciencePortfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more
Contact details available
Steven Robinette
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Contact details available
Michael Gladstone
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Third Harmonic Bio, Surface Oncology, Xilio Therapeutics, Spero Therapeutics
Contact details available
Vikas GoyalVerified
Venture Capital, Angel/Individual · United States
BiotechnologyPortfolio: CalciMedica, Pandion Therapeutics, Spero Therapeutics
Verified email available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Spero Therapeutics investors are on Angel Roster?
Angel Roster lists 23 Spero Therapeutics investors. 13 of them (57%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (22), University Program Investors (8) and Private Equity Firms (5). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Spero Therapeutics investors invest in?
Among those that list a stage, the most common are Series A (5), Seed (3) and Series B (3).
Where are Spero Therapeutics investors based?
Most are based in the United States (22) and the United Kingdom (1).
Which companies have Spero Therapeutics investors backed?
The most-backed portfolio companies among them are Q32 Bio (14), Aerovate Therapeutics (14), Translate Bio (13), Magenta Therapeutics (11) and Affinia Therapeutics (11).
How do I contact Spero Therapeutics investors?
Create a free Angel Roster account to search and filter all 23, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.